Jefferies Group's JAZZ Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 175,599 shares of Jazz Pharmaceuticals plc (JAZZ) worth $33.2 M, representing 0.23% of the portfolio. First purchased in 2023-Q3, this short-term holding has been held for 8 quarters.
Based on 13F filings, Jefferies Group has maintained this position in JAZZ for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 172,099 shares. Largest reduction occurred in Q2 2024, reducing 46,662 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Jazz Pharmaceuticals plc (JAZZ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Jazz Pharmaceuticals plc (JAZZ) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +172,099 | Add 4917.11% | 175,599 | $189.05 |
| Q4 2025 | +3,500 | New Buy | 3,500 | $170.00 |
| Q2 2025 | -11,213 | Sold Out | 0 | $0.00 |
| Q1 2025 | +11,213 | New Buy | 11,213 | $124.15 |
| Q2 2024 | -46,662 | Sold Out | 0 | $0.00 |
| Q1 2024 | -3,815 | Reduce 7.56% | 46,662 | $120.42 |
| Q4 2023 | +48,001 | Add 1938.65% | 50,477 | $123.00 |
| Q3 2023 | +2,476 | New Buy | 2,476 | $129.44 |
Jefferies Group's Jazz Pharmaceuticals plc Investment FAQs
Jefferies Group first purchased Jazz Pharmaceuticals plc (JAZZ) in Q3 2023, acquiring 2,476 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Jazz Pharmaceuticals plc (JAZZ) for 8 quarters since Q3 2023.
Jefferies Group's largest addition to Jazz Pharmaceuticals plc (JAZZ) was in Q1 2026, adding 175,599 shares worth $33.2 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 175,599 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $33.2 M.
As of the Q1 2026 filing, Jazz Pharmaceuticals plc (JAZZ) represents approximately 0.23% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Jazz Pharmaceuticals plc (JAZZ) was 175,599 shares, as reported at the end of Q1 2026.